<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Abstract Objective </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000471'>Gastrointestinal angiodysplasias</z:hpo> recurrently bleed, accounting for 3-5% of obscure <z:hpo ids='HP_0002239'>gastrointestinal bleeding</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The advent of small bowel capsule endoscopy (SBCE) has led to an increased recognition of small bowel <z:e sem="disease" ids="C0267370,C0085411" disease_type="Disease or Syndrome" abbrv="">angiodysplasias</z:e> (SBAs) but little is known about their etiology </plain></SENT>
<SENT sid="3" pm="."><plain>Previous small cohorts and case reports suggest an equal gender incidence and associations with <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e>, <z:e sem="disease" ids="C0341697" disease_type="Disease or Syndrome" abbrv="">renal impairment</z:e>, and <z:hpo ids='HP_0003256'>coagulopathies</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Methods </plain></SENT>
<SENT sid="5" pm="."><plain>Patients with SBA were identified from our SBCE database </plain></SENT>
<SENT sid="6" pm="."><plain>A control group, in whom <z:hpo ids='HP_0002239'>gastrointestinal bleeding</z:hpo> had been excluded, was also identified </plain></SENT>
<SENT sid="7" pm="."><plain>Information on patient demographics, past medical/surgical/social history and medications was prospectively obtained </plain></SENT>
<SENT sid="8" pm="."><plain>Results </plain></SENT>
<SENT sid="9" pm="."><plain>A total of 82 patients and 95 controls were identified </plain></SENT>
<SENT sid="10" pm="."><plain>Data was available from 81% (n = 66) of SBA patients </plain></SENT>
<SENT sid="11" pm="."><plain>The mean age of patients and controls was 66.9 years (35-90) and 69.2 years (54-77), and 60% (n = 40) and 58% (n = 55) were females, respectively </plain></SENT>
<SENT sid="12" pm="."><plain>There was a higher rate of <z:hpo ids='HP_0000001'>all</z:hpo> comorbidities in the SBA group 92% (61/66) versus controls 76% (72/95) p &lt; 0.002 </plain></SENT>
<SENT sid="13" pm="."><plain>Significant associations were found with: <z:hpo ids='HP_0000822'>hypertension</z:hpo> (odds ratio [OR] 2.8), <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e> (OR 4.25), <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> (OR 4.36), <z:hpo ids='HP_0001654'>valvular heart disease</z:hpo> (OR 18), <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo> (OR 4.22), <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> (CKD) (OR 8.4), <z:hpo ids='HP_0011010'>chronic</z:hpo> respiratory conditions (OR 2.0), and previous venous <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> (VTE) (OR 6.4) </plain></SENT>
<SENT sid="14" pm="."><plain><z:chebi fb="3" ids="50249">Anticoagulant</z:chebi> use was higher in patients with SBA, 50% (n = 33) versus 27% (n = 26) of controls, p &lt; 0.002, specifically <z:chebi fb="8" ids="10033">warfarin</z:chebi> and asasantin retard </plain></SENT>
<SENT sid="15" pm="."><plain>Conclusions </plain></SENT>
<SENT sid="16" pm="."><plain>SBA occurs in elderly patients with <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> and CKD, as previously suggested </plain></SENT>
<SENT sid="17" pm="."><plain>This study identifies a previously unrecognised risk in females, patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> respiratory conditions and VTE, and the use of <z:chebi fb="8" ids="10033">warfarin</z:chebi> and asasantin retard </plain></SENT>
<SENT sid="18" pm="."><plain>These associations should raise awareness of possible underlying SBA in risk patients with <z:hpo ids='HP_0001903'>anemia</z:hpo> </plain></SENT>
</text></document>